vs

Side-by-side financial comparison of Idaho Strategic Resources, Inc. (IDR) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

NEKTAR THERAPEUTICS is the larger business by last-quarter revenue ($21.8M vs $14.6M, roughly 1.5× Idaho Strategic Resources, Inc.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -165.4%, a 229.7% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs -25.3%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $-65.0M). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs 0.4%).

Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

IDR vs NKTR — Head-to-Head

Bigger by revenue
NKTR
NKTR
1.5× larger
NKTR
$21.8M
$14.6M
IDR
Growing faster (revenue YoY)
IDR
IDR
+117.3% gap
IDR
92.0%
-25.3%
NKTR
Higher net margin
IDR
IDR
229.7% more per $
IDR
64.3%
-165.4%
NKTR
More free cash flow
IDR
IDR
$73.1M more FCF
IDR
$8.2M
$-65.0M
NKTR
Faster 2-yr revenue CAGR
IDR
IDR
Annualised
IDR
57.2%
0.4%
NKTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IDR
IDR
NKTR
NKTR
Revenue
$14.6M
$21.8M
Net Profit
$9.4M
$-36.1M
Gross Margin
68.5%
Operating Margin
62.4%
-126.9%
Net Margin
64.3%
-165.4%
Revenue YoY
92.0%
-25.3%
Net Profit YoY
220.6%
-596.9%
EPS (diluted)
$0.62
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDR
IDR
NKTR
NKTR
Q4 25
$14.6M
$21.8M
Q3 25
$11.1M
$11.8M
Q2 25
$9.5M
$11.2M
Q1 25
$7.3M
$10.5M
Q4 24
$7.6M
$29.2M
Q3 24
$6.2M
$24.1M
Q2 24
$6.1M
$23.5M
Q1 24
$5.9M
$21.6M
Net Profit
IDR
IDR
NKTR
NKTR
Q4 25
$9.4M
$-36.1M
Q3 25
$3.0M
$-35.5M
Q2 25
$2.8M
$-41.6M
Q1 25
$1.6M
$-50.9M
Q4 24
$2.9M
$7.3M
Q3 24
$1.6M
$-37.1M
Q2 24
$2.2M
$-52.4M
Q1 24
$2.2M
$-36.8M
Gross Margin
IDR
IDR
NKTR
NKTR
Q4 25
68.5%
Q3 25
63.6%
Q2 25
57.8%
Q1 25
50.8%
Q4 24
53.3%
72.7%
Q3 24
48.7%
81.6%
Q2 24
50.2%
58.5%
Q1 24
48.1%
60.6%
Operating Margin
IDR
IDR
NKTR
NKTR
Q4 25
62.4%
-126.9%
Q3 25
23.4%
-268.6%
Q2 25
26.6%
-324.2%
Q1 25
19.3%
-425.8%
Q4 24
36.2%
49.2%
Q3 24
23.4%
-142.4%
Q2 24
34.2%
-211.9%
Q1 24
36.3%
-163.7%
Net Margin
IDR
IDR
NKTR
NKTR
Q4 25
64.3%
-165.4%
Q3 25
26.8%
-301.3%
Q2 25
29.2%
-372.2%
Q1 25
22.1%
-486.4%
Q4 24
38.5%
24.9%
Q3 24
25.8%
-153.6%
Q2 24
35.2%
-222.9%
Q1 24
36.8%
-170.1%
EPS (diluted)
IDR
IDR
NKTR
NKTR
Q4 25
$0.62
$-4.67
Q3 25
$0.20
$-1.87
Q2 25
$0.20
$-2.95
Q1 25
$0.12
$-0.24
Q4 24
$0.21
$-2.07
Q3 24
$0.12
$-2.66
Q2 24
$0.17
$-3.76
Q1 24
$0.17
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDR
IDR
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$15.1M
Total DebtLower is stronger
$2.3M
Stockholders' EquityBook value
$108.2M
$89.8M
Total Assets
$116.2M
$280.4M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDR
IDR
NKTR
NKTR
Q4 25
$15.1M
Q3 25
$41.0M
Q2 25
$43.0M
Q1 25
$38.9M
Q4 24
$44.3M
Q3 24
$30.1M
Q2 24
$6.3M
$27.9M
Q1 24
$5.3M
$48.6M
Total Debt
IDR
IDR
NKTR
NKTR
Q4 25
$2.3M
Q3 25
$3.0M
Q2 25
$3.3M
Q1 25
$3.7M
Q4 24
$1.7M
Q3 24
$2.9M
Q2 24
$2.7M
Q1 24
$3.3M
Stockholders' Equity
IDR
IDR
NKTR
NKTR
Q4 25
$108.2M
$89.8M
Q3 25
$74.3M
$85.1M
Q2 25
$49.3M
$-24.2M
Q1 25
$39.8M
$13.7M
Q4 24
$37.7M
$60.7M
Q3 24
$33.1M
$48.9M
Q2 24
$25.4M
$79.7M
Q1 24
$21.6M
$126.7M
Total Assets
IDR
IDR
NKTR
NKTR
Q4 25
$116.2M
$280.4M
Q3 25
$83.1M
$301.3M
Q2 25
$57.7M
$207.5M
Q1 25
$48.1M
$256.2M
Q4 24
$44.0M
$303.9M
Q3 24
$40.8M
$308.0M
Q2 24
$32.2M
$343.3M
Q1 24
$28.7M
$396.0M
Debt / Equity
IDR
IDR
NKTR
NKTR
Q4 25
0.02×
Q3 25
0.04×
Q2 25
0.07×
Q1 25
0.09×
Q4 24
0.05×
Q3 24
0.09×
Q2 24
0.11×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDR
IDR
NKTR
NKTR
Operating Cash FlowLast quarter
$10.7M
$-65.0M
Free Cash FlowOCF − Capex
$8.2M
$-65.0M
FCF MarginFCF / Revenue
56.0%
-298.0%
Capex IntensityCapex / Revenue
17.7%
0.1%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$12.4M
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDR
IDR
NKTR
NKTR
Q4 25
$10.7M
$-65.0M
Q3 25
$2.4M
$-48.8M
Q2 25
$3.5M
$-45.7M
Q1 25
$2.4M
$-49.1M
Q4 24
$3.2M
$-46.2M
Q3 24
$2.5M
$-43.9M
Q2 24
$2.6M
$-37.7M
Q1 24
$2.6M
$-47.9M
Free Cash Flow
IDR
IDR
NKTR
NKTR
Q4 25
$8.2M
$-65.0M
Q3 25
$709.8K
$-48.9M
Q2 25
$2.5M
$-45.8M
Q1 25
$1.0M
$-49.1M
Q4 24
$2.1M
$-46.6M
Q3 24
$1.9M
$-44.6M
Q2 24
$2.4M
$-37.9M
Q1 24
$2.3M
$-48.0M
FCF Margin
IDR
IDR
NKTR
NKTR
Q4 25
56.0%
-298.0%
Q3 25
6.4%
-414.5%
Q2 25
26.5%
-409.6%
Q1 25
13.8%
-469.0%
Q4 24
28.0%
-159.9%
Q3 24
30.4%
-184.9%
Q2 24
38.7%
-161.3%
Q1 24
38.3%
-222.0%
Capex Intensity
IDR
IDR
NKTR
NKTR
Q4 25
17.7%
0.1%
Q3 25
15.3%
1.0%
Q2 25
10.8%
0.3%
Q1 25
19.4%
0.0%
Q4 24
13.6%
1.6%
Q3 24
9.8%
2.8%
Q2 24
4.3%
0.8%
Q1 24
5.5%
0.7%
Cash Conversion
IDR
IDR
NKTR
NKTR
Q4 25
1.15×
Q3 25
0.81×
Q2 25
1.28×
Q1 25
1.50×
Q4 24
1.08×
-6.36×
Q3 24
1.56×
Q2 24
1.22×
Q1 24
1.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons